JP Morgan Chase’s Oxford Immunotec Global OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-8,231
Closed -$97K – 6136
2020
Q3
$97K Sell
8,231
-91,955
-92% -$1.22M ﹤0.01% 4708
2020
Q2
$1.3M Sell
100,186
-1,993
-2% -$23.9K ﹤0.01% 3364
2020
Q1
$946K Sell
102,179
-13,174
-11% -$184K ﹤0.01% 3425
2019
Q4
$1.92M Buy
115,353
+656
+0.6% +$10.6K ﹤0.01% 3420
2019
Q3
$1.91M Buy
114,697
+20,343
+22% +$281K ﹤0.01% 3454
2019
Q2
$1.3M Buy
94,354
+3,157
+3% +$48.3K ﹤0.01% 3683
2019
Q1
$1.57M Buy
91,197
+70,976
+351% +$1.12M ﹤0.01% 3509
2018
Q4
$259K Sell
20,221
-60,042
-75% -$911K ﹤0.01% 4471
2018
Q3
$1.3M Buy
80,263
+14,904
+23% +$213K ﹤0.01% 3742
2018
Q2
$842K Buy
65,359
+45,805
+234% +$619K ﹤0.01% 3927
2018
Q1
$243K Buy
19,554
+14,092
+258% +$172K ﹤0.01% 4302
2017
Q4
$76K Buy
+5,462
New +$80K ﹤0.01% 4761
2017
Q2
– Sell
-30,468
Closed -$472K – 5345
2017
Q1
$472K Sell
30,468
-12,382
-29% -$177K ﹤0.01% 3741
2016
Q4
$641K Buy
+42,850
New +$602K ﹤0.01% 3637

Other funds holding OXFD

JP Morgan Chase's OXFD Position: Q4 2020 in Review

JP Morgan Chase sold out of Oxford Immunotec Global (OXFD) in Q4 2020, closing a stake of 8,231 shares — an estimated $97K sold.

JP Morgan Chase first reported a position in OXFD in Q4 2016 and held it in 14 quarters. The position peaked at $1.92M in Q4 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

  • JP Morgan Chase reported no remaining Oxford Immunotec Global position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 8,231 Oxford Immunotec Global shares in Q4 2020, an estimated $97K.
  • JP Morgan Chase first reported a position in Oxford Immunotec Global in Q4 2016 and held it in 14 quarters.
  • JP Morgan Chase's Oxford Immunotec Global position peaked at $1.92M in Q4 2019.
  • 60 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.